BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26095883)

  • 21. Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence.
    McGurk L; Rifai OM; Shcherbakova O; Perlegos AE; Byrns CN; Carranza FR; Zhou HW; Kim HJ; Zhu Y; Bonini NM
    Hum Mol Genet; 2021 Sep; 30(19):1797-1810. PubMed ID: 34077532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
    Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis.
    Liu X; Lu M; Tang L; Zhang N; Chui D; Fan D
    Neurobiol Aging; 2013 Sep; 34(9):2236.e5-8. PubMed ID: 23635656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications.
    Hart MP; Gitler AD
    J Neurosci; 2012 Jul; 32(27):9133-42. PubMed ID: 22764223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CAG repeats ≥ 34 in Ataxin-1 gene are associated with amyotrophic lateral sclerosis in a Brazilian cohort.
    Gonçalves JPN; de Andrade HMT; Cintra VP; Bonadia LC; Leoni TB; de Albuquerque M; Martins MP; de Borba FC; Couteiro RED; de Oliveira DS; Claudino R; Gonçalves MVM; Dourado ME; de Souza LC; Teixeira AL; de Godoy Rousseff Prado L; Tumas V; Oliveira ASB; Nucci A; Lopes-Cendes I; Marques W; França MC
    J Neurol Sci; 2020 Jul; 414():116842. PubMed ID: 32339968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis.
    Figley MD; Thomas A; Gitler AD
    Neurobiol Aging; 2014 Apr; 35(4):936.e1-4. PubMed ID: 24269018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism.
    Zhang M; Xi Z; Misquitta K; Sato C; Moreno D; Liang Y; Slow E; Rogaeva E; Tartaglia MC
    Mov Disord; 2017 Jan; 32(1):158-162. PubMed ID: 28124431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
    Bäumer D; East SZ; Tseu B; Zeman A; Hilton D; Talbot K; Ansorge O
    Acta Neuropathol; 2014 Oct; 128(4):597-604. PubMed ID: 24718895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.
    Bury JJ; Highley JR; Cooper-Knock J; Goodall EF; Higginbottom A; McDermott CJ; Ince PG; Shaw PJ; Kirby J
    Neuropathology; 2016 Apr; 36(2):125-34. PubMed ID: 26303227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis.
    Neuenschwander AG; Thai KK; Figueroa KP; Pulst SM
    JAMA Neurol; 2014 Dec; 71(12):1529-34. PubMed ID: 25285812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72.
    McGurk L; Lee VM; Trojanowksi JQ; Van Deerlin VM; Lee EB; Bonini NM
    J Neuropathol Exp Neurol; 2014 Sep; 73(9):837-45. PubMed ID: 25111021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
    Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S
    Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALS-associated genes in SCA2 mouse spinal cord transcriptomes.
    Scoles DR; Dansithong W; Pflieger LT; Paul S; Gandelman M; Figueroa KP; Rigo F; Bennett CF; Pulst SM
    Hum Mol Genet; 2020 Jun; 29(10):1658-1672. PubMed ID: 32307524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis.
    Chen Y; Huang R; Yang Y; Chen K; Song W; Pan P; Li J; Shang HF
    Neurobiol Aging; 2011 Oct; 32(10):1925.e1-5. PubMed ID: 21741123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS.
    Bonini NM; Gitler AD
    J Mol Neurosci; 2011 Nov; 45(3):676-83. PubMed ID: 21660502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATXN2 intermediate repeat expansions influence the clinical phenotype in frontotemporal dementia.
    Rubino E; Mancini C; Boschi S; Ferrero P; Ferrone M; Bianca S; Zucca M; Orsi L; Pinessi L; Govone F; Vacca A; Gai A; Giordana MT; Brusco A; Rainero I
    Neurobiol Aging; 2019 Jan; 73():231.e7-231.e9. PubMed ID: 30342763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
    Van Damme P; Veldink JH; van Blitterswijk M; Corveleyn A; van Vught PW; Thijs V; Dubois B; Matthijs G; van den Berg LH; Robberecht W
    Neurology; 2011 Jun; 76(24):2066-72. PubMed ID: 21562247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggressive disease phenotype.
    Ghezzi A; Martinelli I; Carra S; Mediani L; Zucchi E; Simonini C; Gianferrari G; Fini N; Cereda C; Gellera C; Pensato V; Mandrioli J
    Neurol Sci; 2022 Oct; 43(10):6087-6090. PubMed ID: 35731316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias.
    Fournier C; Anquetil V; Camuzat A; Stirati-Buron S; Sazdovitch V; Molina-Porcel L; Turbant S; Rinaldi D; Sánchez-Valle R; Barbier M; Latouche M; ; Stevanin G; Seilhean D; Brice A; Duyckaerts C; Le Ber I
    Acta Neuropathol Commun; 2018 May; 6(1):41. PubMed ID: 29848387
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations.
    Naruse H; Matsukawa T; Ishiura H; Mitsui J; Takahashi Y; Takano H; Goto J; Toda T; Tsuji S
    Neurogenetics; 2019 May; 20(2):65-71. PubMed ID: 30847648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.